Anglonordic Biotech Conference
The Anglo-Nordic region continues to be one of the fastest growing biotech regions in the world. Now entering our ninth year, the Anglonordic Biotech Conference provides the ideal one-stop opportunity to discover, collaborate and invest in this success. By invitation only,the select audience is restricted to decision makers, representing drug discovery-, pharmaceutical and venture capital firms.

The conference consists of four areas that have on-going activities simultaneously. The four areas are; the Main Conference Room, Aescap Venture Investment Room, the One-to-One Meetings Area and the Exhibition/Lounge Area.The conference starts with a reception the evening before (23rd of May) at the Swedish Ambassador’s Residence in London. Please see text below for more information about the most recent conference, pictures and delegate comments.

 

To view the Sponsorship Catalouge 2012 - Click here

Evaluation of ABC VIII
To VIEW PICTURES and read the FULL version of the Evaluation of ABC VIII, 5 May 2011, Click here

In total 240 key decision makers from 180 drug discovery-, pharmaceutical- and venture capital companies attended the ABC VIII. The conference started with a reception the evening before the event at the Norwegian Ambassador’s Residence in London. Belgium was the Guest Country 2011.

Official statements from previous ABC conferences:

Danny Chan, Editor, Thomson Reuters
I really liked the idea that the official start of the conference was preceded by some informal drinks. The talks were really good in that the information on offer seemed previously undisclosed, which is great from a journalist point of view.

Professor Nicholas Barnes, CEO, Celentyx
Once again the Anglonordic Biotech Conference has delivered a very useful networking opportunity. We are very pleased with the business this conference generates for our company.

Dr Anders Weber, Board member, RSP Systems A/S
The format of a one day conference at a convenient location is great. The event is refreshingly simple and efficient!

Rob Pinnock, Director Scientific Liaison, Merck & Co
We sponsor this because it is a productive meeting at a good time of the year.

Jane Worlock, CBO, Akthelia Pharmaceuticals
Another great conference in 2010. We received some genuine interest and leads for follow-up regarding inward investment

Nori Matsuo, Apposite Capital
I think ABC is a higher conference. I hope ABC could continue this events. I have interests in contacts to Investors as well as Biotech.

Martin Welschof, Managing Director, Affitech
I like ABC because the meeting has critical mass but still provides a private and intimate atmosphere; which is the key to high quality interaction and communication.

Erik Christensen, CEO, DiaGenic ASA
A very good meeting place and communication tool for Nordic companies (SME) towards the UK market. Please continue the good work.

Anna Kalmi, Vice President, Innomedica Ltd
Great conference with high quality presentations. Right people, right size and right scale.

Jonathan Hepple, Partner, Rosetta Capital
An excellent opportunity to identify promising investment opportunities

Per Lek, Senior Partner, Acure Pharma AB
Nice informal atmosphere, with big pharma, big investors and small biotech companies making it an excellent conference to find old and new colleagues and potential partners.

Invitations - The conference is free of charge and by invitation only. If you are interested to attend the conference or if have you any questions regarding your invitation then please contact Daniel Johansson on +44 (0)20 7795 8132 or by email
daniel@anglonordicbiotech.com.

For more information about how to become a sponsor, click here.